Important players in mammalian cells include mitofusin 1 and 2 (MFN1 and MFN2), optic atrophy 1 (OPA1) and dynamin-related protein 1 (DRP1). Several triggers, including oxidative stress and ...

Biotech player PYC Therapeutics (ASX:PYC) has dosed its first patient in a clinical trial seeking to ameliorate symptoms of ...

The most common of these syndromes include hearing loss or obesity, as well as retinal degeneration and/or optic atrophy, and some not only severely affect the overall quality of life of patients ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has dosed its first patient in a clinical trial for its innovative ...

PYC Therapeutics (ASX:PYC) has announced significant progress in its efforts to develop RNA-based precision medicines for ...